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ABSTRACT 
The seroprevalence of hepatitis B virus (HBsAg) antibodies in pregnant women were 
determined using the rapid kit with double sandwich antibody procedure. Eight 
hundred and sixty pregnant women were recruited for this study. Out of this number 
forty (4.7%) were positive while eight hundred and twenty (95.3%) were negative, 
indicating an overall prevalence of 4.7%. It therefore implies that the area under study 
showed low endemicity for the infection. It was also observed that health status of the 
women and their history of travels outside Akure, Ondo State was not associated with 
HBsAg seropositivity. The significance of these findings is discussed. 
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INTRODUCTION 
Hepatitis B. Virus (HBV) infection has been reported as the most common cause of serious liver infection 
in the world (Uneke, 2005; Pineau and Tiollais, 2009). The infection has consequently been referred to as a 
public health problem worldwide (Vazquez Martinez, 2003). 
 
The infection can be acute or chronic, but while adults that acquire acute infection usually recover (Awole 
and Gebre-Selassie, 2005; Buster et al., 2008) or can be managed by supportive therapy, the chronic type is 
ultimately fatal. Estimate has it that worldwide more than two billion people have been infected by HBV 
and about 350 million people had the chronic infection (Drosten et al., 2004; Buster et al., 2008). WHO 
(1996) reported that approximately one million people died yearly because of the association between HBV 
infection and the development of chronic clinical conditions such as chronic active hepatitis cirrhosis and 
hepatic carcinoma. The prevalence of HBV infection is relatively higher in the tropics (Finlayson et al., 
1998; Hannachi et al., 2009) and Africa region has been reported highly endemic for the infection, giving it 
the second greater number of chronically HBV infected individuals (Kiire, 1996; Hannachi et al., 2009).  
 
Nigeria, a tropical country, has been documented as highly endemic for HBV infection and about 75% of 
its population is likely to have been exposed to the virus at one time or the other in their lives (Sirisena et 
al., 2002; ). Transplacental transmission of the virus was suggested since HBV antibodies were detected in 
cord blood of some mothers who had just been delivered of their babies ( Hannachi et al., 2009). This 
present work is aimed at determining the prevalence rate of HBV in pregnant women with a view of 
suggesting the possibility of maternally transferred HBV or its antibodies during either child delivery or 
breast feeding.    
 
METHODOLOGY 
Study Area 
This study was conducted in Akure South Local Government Area (LGA) of Ondo state. This is one of the 
largest LGA’s in Ondo State. The study population was a mixture of people from different parts of the 
country but largely comprised the indigenes. The main occupation of the people is civil servant, trading and 
other forms of business. In general the population has high socio-economic and sanitation levels. 
 
Study Design 
In order to obtain a representative sample, the most utilized health facility (State Specialist Hospital, 
Akure), was used for the study. Following approval from the management of the hospital to carry out the  
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study, the aim of the study was explained to randomly selected apparently healthy pregnant women 
attending antenatal clinic, after which 860 pregnant women gave verbal consents. Well structured 
questionnaire was used to obtain subjects attributes considered as risk factors for HBV infections. Blood 
samples were subsequently taken from these pregnant women. 
 
Serological Test 
Five ml of blood sample was aseptically collected by venepuncture from each subject into appropriate 
labeled anticoagulant free blood sample bottles. The blood samples were left to clot, after which sera were 
separated from the clotted blood by centrifugation. The sera samples were stored at +40C until screened. 
Antibodies to HBsAg was determined using rapid kit with double sandwich antibody procedure   
(Clinotech TM Diagnostics and Pharmaceuticals Inc. Canada). The test was carried out according to 
manufacturers’ protocol. The test device was removed from the pouch. The test strip was dipped into fresh 
serum specimen for one minute with the arrow pointing down; taking care to ensure the marker line on the 
strip was not immersed in the serum. The strip was then laid flat on clean, non-absorbent test bench with 
each strip placed beside each labeled sample tube for identification. The test results were read by observing 
the line bands on the test strips after one minute. Interpretation of results was done according to 
manufacturer’s instruction.  
 
RESULTS 
The total number of pregnant women enrolled in the study was 860 with median and mode age of 25-29 
years. Fifty three percent (53%) of the pregnant women were young adults (20-29 years). Only 1% of the 
subjects were illiterate. The rest 99% had at least primary school Education. The highest educational level 
observed for the women was Higher National Diploma. The results of the pregnant women are shown in 
(Table 1). Eight hundred and twenty (95.3%) women tested negative for antibodies to HBV while only 
forty (4.7%) women tested positive. Twenty four of the positive cases were from the 22-26 age range while 
the remaining sixteen were from the 27-31 age range. 
 
DISCUSSION 
This study showed that the prevalence of hepatitis B virus (HBV) infection in apparently healthy pregnant 
women attending antenatal clinic (ANC) in state specialist hospital, Akure, Ondo State, was 4.7%. This 
indicated that five in about a thousand pregnant women studied was seropositive for HBaAg. In addition 
since Hodges et al., (1998) reported that HBV seroprevalence greater than 7% in adult population in a 
given location classified such  location as highly endemic for HBV infection. HBsAg seroprevalence of 
4.7% in adult pregnant women screened in Akure, classifies it low endemic for the infection. The HBsAg 
seroprevalence of 4.7% reported in this study is lower than 12% reported among pregnant women (n= 100) 
attending antenatal (ANC) in Central Hospital, Warri, Delta State (Ophori et al., 2004). It is also lower than 
the reported HBsAg seropositivity of 9.3% (n = 1, 120) in attendees of ANC (16 – 50 year) Awka, 
Anambra  State, Nigeria (Ezegbudo et al, 2004). 
 
Analysis of data considered as risk factors for HBV infection in the studied subjects revealed that only age, 
occupation and occupation of their husbands appeared associated with the infection. 
 
There was highly significant association (P = 40%) between age of the pregnant women and occurrence of 
HBV infection. This might be due to the reason offered by Mehment et al.,(2005) that exposure to HBV 
increased with age in urban and rural areas. Occupation of the pregnant women also showed significantly 
high association (P = 22.2 %) with HBV infection. The HBsAg seropositivity was highest for the pregnant 
women who were business women. A striking observation made in this study was the zero HBsAg 
seropositivity for the subjects who were Farmers. This finding was corroborated by the fact that non of the 
pregnant women having farmers as husbands tested seropositive for the HBsAg. The reason for this 
observation was not immediately apparent. A further study targeting men and women that are farmers may 
reveal the possible reasons. It was also observed that there was high significant association (P = 40%) 
between occupation of the subjects husbands and HBsAg seropositivity, with husbands who were Driver 
and Engineer having HBaAg seroprevalence of 13% and 11.7 % respectively, though one of the pregnant  
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Table 1. Data of pregnant women recruited for HBV antibodies screening. 
Data Number tested Number positive Percentage 
Age range    
17  -21 43 0 0.0 
22  - 26 258 24 9.3 
27  -  31 318 16 5.0 
32  -  36 163 0 0.0 
37  -  41 69 0 0.0 
42  -  47 9 0 0.0 
Educational status    
Illiterate 9 0 0.0 
Primary School  25 0 0.0 
High School or more 826 40 4.8 
Subject Occupation    
Business 77 13 16.9 
Hair Dresser 60 9 15.0 
Trading 241 9 3.7 
Teaching 86 0 0.0 
Civil Servant 95 9 9.5 
Tailor 69 0 0.0 
Applicants 43 0 0.0 
Youth copper 9 0 0.0 
Caterer 17 0 0.0 
Farming 9 0 0.0 
Lawyer 17 0 0.0 
Health worker 9 0 0.0 
Students 129 0 0.0 
Husband Occupation    
Business 146 0 0.0 
Civil Servant 201 24 11.9 
Furniture 60 0 0.0 
Lawyer 17 0 0.0 
Health worker 9 0 0.0 
Driver 69 9 13.0 
Engineer 60 7 11.7 
Tailor 34 0 0.0 
Clergy 34 0 0.0 
Teaching 170 0 0.0 
    
Policemen 17 0 0.0 
Farming 17 0 0.0 
Barbing 9 0 0.0 
Student 17 0 0.0 
History of Blood Transfusion    
Yes 9 0 0.0 
No 851 40 4.7 
History of travel 
outside Ondo State 
Number tested Number positive Percentage  
Yes 845 35 4.1 
o 15 5 33.3 
History of STD    
Yes 0 0 0.0 
No 860 40 4.7 
 STD = Sexually Transmitted Disease  
 
9 
 
Ojo, O.O and Anibijuwon I.I: Continental J. Microbiology 3: 6 - 10, 2009. 
 
 
women was a health worker. Pregnant women who were positive for HBV stand the risk of transmitting the 
virus to their unborn child during delivery or during breast feeding of the baby after delivery. The 
introduction of  HBV vaccine as one of the routine vaccines for pregnant women will help  checkmate the 
transmission cycle of HBV and subsequently preventing mother to child transmission. 
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